This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
The permit or its equivalent related to this internationally recognized certificate of compliance (IRCC) has expired.
Organization:Department of Environmental Affairs (DEA)Government agency (National/Federal)Ms Nosipho NgcabaDirector-General, Department of Environmental Affairs473 Steve Biko Road, ArcadiaPretoria, Gauteng Province
0001, South AfricaPhone: +2712 399 9611,Fax: +2712 359 3625,Email: BABS@environment.gov.za,Website: http://environment.gov.za,
Application for a permit to conduct bioprospecting involving indigenous genetic and biological resources and associated traditional knowledge in terms of the National Environmental Managament:Biodiversity Act, 2004 (Act No. 10 of 2004) and the Bioprospecting, Access and Benefit Sharing Regulations.
Organization:Department of Environmental Affairs (DEA)Government agency (National/Federal)Ms Nosipho NgcabaDirector-General, Department of Environmental Affairs473 Steve Biko Road, ArcadiaPretoria, Gauteng Province
0001, South AfricaPhone: +2712 399 9611,Fax: +2712 359 3625,Email: BABS@environment.gov.za,Website: http://www.environment.gov.za,
Organization:HG&H Pharmaceuticals (Pty) Ltd (HGH)Private sector (business and industry)Dr Nigel Peter GerickeDirector, HG&H Pharmaceuticals (Pty) LtdBlock 9, 1st Floor Wedgewood Office Park, BryanstonJohannesburg, Gauteng Province
2021, South AfricaPhone: +2721 8833189,Fax: +2721 883 8910,Email: info@zembrin.com,Website: http://www.zembrin.com,
HG&H Pharmaceuticals (Pty) Ltd may only use the Sceletium tortuosum for the purpose specified in the permit application documentation.
HG&H Pharmaceuticals (Pty) Ltd must submit progress report annually for the duration f the permit.
If new collaborators join the bioprospecting project for which the permit has been issued, HG&H Pharmaceuticals must notify the issuing authority in writing.
All money due to the South African San Council and the Nama Community in terms of a concluded benefit sharing agreement must be paid into the Bioprospecting Trust Fund, as required by section 85 (1) of the Act.
Conduct national and international research and development on Sceletium tortuosum and associated traditional knowledge and commercialise the final product.
- Commercial
HG&H Pharmaceuticals (Pty) Ltd will be liable for the costs of mitigating or remedying the impact of the bioprosecting on the environment, in accordnance with section 28 of the National Environmental Management Act, 1998 ( Act No. 107 of 1998)
HG&H Pharmaceuticals (Pty) Ltd must comply with all other legislative requirements for export outside the Republic of South Africa
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-ZA-206780-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Lactitia Tshitwamulomoni (lmabadahane@environment.gov.za)
23 Mar 2016 12:34 on 23 Mar 2016 12:34
|
